JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 46 filers reported holding JANUX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $863,937 | -47.0% | 85,708 | -37.6% | 0.01% | -47.4% |
| Q2 2023 | $1,629,751 | -1.9% | 137,300 | 0.0% | 0.02% | -17.4% |
| Q1 2023 | $1,661,330 | -75.0% | 137,300 | -72.8% | 0.02% | -74.2% |
| Q4 2022 | $6,655,644 | +22.8% | 505,364 | +26.3% | 0.09% | +17.1% |
| Q3 2022 | $5,418,000 | +54.9% | 400,181 | +39.7% | 0.08% | +40.7% |
| Q2 2022 | $3,497,000 | -12.4% | 286,383 | +2.9% | 0.05% | -16.9% |
| Q1 2022 | $3,991,000 | -27.3% | 278,323 | +0.0% | 0.06% | -17.7% |
| Q4 2021 | $5,490,000 | -15.4% | 278,275 | -7.3% | 0.08% | -25.5% |
| Q3 2021 | $6,490,000 | -22.2% | 300,031 | -10.2% | 0.11% | -32.1% |
| Q2 2021 | $8,340,000 | – | 334,260 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $216,333,000 | 3.47% |
| 5AM Venture Management, LLC | 446,266 | $11,134,000 | 2.80% |
| Samsara BioCapital, LLC | 607,949 | $15,168,000 | 1.87% |
| EcoR1 Capital, LLC | 1,411,975 | $35,229,000 | 1.32% |
| Logos Global Management LP | 547,122 | $13,651,000 | 1.15% |
| BVF INC/IL | 1,176,681 | $29,358,000 | 1.10% |
| Orbimed Advisors | 3,466,386 | $86,486,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 700,000 | $17,465,000 | 0.31% |
| Pinz Capital Management, LP | 32,100 | $801,000 | 0.24% |
| Woodline Partners LP | 334,260 | $8,340,000 | 0.16% |